Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer

Journal article

Navid Sobhani, Daniele Generali, Alberto D'Angelo, Michele Aieta, Giandomenico Roviello
Invest New Drugs, vol. 36(6), 2018, pp. 1133-1137

DOI: 10.1007/s10637-018-0653-2

Cite

APA Click to copy
Sobhani, N., Generali, D., D'Angelo, A., Aieta, M., & Roviello, G. (2018). Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer. Invest New Drugs, 36(6), 1133–1137. https://doi.org/10.1007/s10637-018-0653-2

Chicago/Turabian Click to copy
Sobhani, Navid, Daniele Generali, Alberto D'Angelo, Michele Aieta, and Giandomenico Roviello. “Current Status of Androgen Receptor-Splice Variant 7 Inhibitor Niclosamide in Castrate-Resistant Prostate-Cancer.” Invest New Drugs 36, no. 6 (2018): 1133–1137.

MLA Click to copy
Sobhani, Navid, et al. “Current Status of Androgen Receptor-Splice Variant 7 Inhibitor Niclosamide in Castrate-Resistant Prostate-Cancer.” Invest New Drugs, vol. 36, no. 6, 2018, pp. 1133–37, doi:10.1007/s10637-018-0653-2.

BibTeX Click to copy

@article{navid2018a,
  title = {Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer},
  year = {2018},
  issue = {6},
  journal = {Invest New Drugs},
  pages = {1133-1137},
  volume = {36},
  doi = {10.1007/s10637-018-0653-2},
  author = {Sobhani, Navid and Generali, Daniele and D'Angelo, Alberto and Aieta, Michele and Roviello, Giandomenico}
}